X

Mental Health & Addiction (MHA) Community

Mental illness and addiction affect at least 1 in 5 adults in the US and represent a substantial burden to individuals and their family as well as to society. The goal of this Community is to increase awareness in topics relevant to the pharmacological treatment of mental health and addiction, increase diversity in the society by attracting new members, and inspire our current members to think more critically about developing research towards understanding the etiology, targeting novel therapeutic approaches, and personalized therapy for these debilitating illnesses.

Vijay Ramchandani, PhD

Community Chair

 

MP McRae

MaryPeace McRae, PharmD, PhD

Community Vice Chair

 

Kristin Bigos, PhD

Community Past Chair

 

Photo Gallery
Recent News
  • ASCPT Members-Only Webinar Presented by the Pharmacometrics & Pharmacokinetics (PMK) and Regulatory Science (RS) Communities
    January 20, 2021
  • 2020 in the Year-View Mirror: Full Speed Ahead to 2021
    January 18, 2021
  • FDA News: Issue 2, January 2021
    January 13, 2021
Contact Us